Browse > Article
http://dx.doi.org/10.5090/jcs.22.029

The Impact of Surgical versus Transcatheter Aortic Valve Replacement on Postprocedural Acute Kidney Injury in Patients with Chronic Kidney Disease  

Eun Chae, Kim (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Sue Hyun, Kim (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Yeiwon, Lee (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Suk Ho, Sohn (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Jae Woong, Choi (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Jeehoon, Kang (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Jung Kyu, Han (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Kyung Hwan, Kim (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Hyo-Soo, Kim (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Ho Young, Hwang (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Publication Information
Journal of Chest Surgery / v.55, no.6, 2022 , pp. 435-441 More about this Journal
Abstract
Background: This study aimed to evaluate the impact of the treatment modality on post-procedural acute kidney injury (AKI) and other clinical outcomes in patients with advanced chronic kidney disease who underwent surgical or transcatheter aortic valve replacement (AVR). Methods: A total of 147 patients with advanced chronic kidney disease (stage 3 to 5) who underwent isolated surgical AVR (SAVR group; n=70) or transcatheter AVR (TAVR group; n=77) were retrospectively studied. Postprocedural AKI was defined according to the RIFLE definition (an acronym corresponding to the risk of renal dysfunction, injury to the kidney, failure of kidney function, loss of kidney function, and end-stage kidney disease). Factors associated with postoperative complications and mortality were analyzed using multivariable logistic regression models and Cox proportional hazard models. Results: Postprocedural AKI occurred in 17 (24.3%) and 6 (7.8%) patients in the SAVR and TAVR groups, respectively (p=0.006). Multivariable analyses demonstrated that the SAVR group had higher risks of AKI (odds ratio [OR], 5.63; 95% confidence interval [CI], 1.85-17.73; p=0.002) and atrial fibrillation (OR, 16.65; 95% CI, 4.44-62.50; p<0.001), whereas the TAVR group had a higher risk of permanent pacemaker insertion (OR, 5.67; 95% CI, 1.21-26.55; p=0.028). The Cox proportional hazard models showed that the occurrence of AKI, contrary to the treatment modality, was associated with overall survival. Conclusion: In patients with chronic kidney disease, the risk of postprocedural AKI might be higher after SAVR than after TAVR.
Keywords
Aortic valve; Surgery; Transcatheter aortic valve replacement; Chronic renal insufficiency; Acute kidney injury;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Head SJ, Milojevic M, Daemen J, et al. Stroke rates following surgical versus percutaneous coronary revascularization. J Am Coll Cardiol 2018;72:386-98. https://doi.org/10.1016/j.jacc.2018.04.071    DOI
2 Karkouti K, Wijeysundera DN, Yau TM, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009;119:495-502. https://doi.org/10.1161/CIRCULATIONAHA.108.786913    DOI
3 Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment: an update. Eur J Cardiothorac Surg 2002;21:232-44. https://doi.org/10.1016/s1010-7940(01)01099-5    DOI
4 Haase M, Bellomo R, Story D, et al. Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on post-operative acute kidney injury. Nephrol Dial Transplant 2012;27:153-60. https://doi.org/10.1093/ndt/gfr275    DOI
5 Venturi G, Scarsini R, Pighi M, et al. Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI. Catheter Cardiovasc Interv 2022;99:1925-34. https://doi.org/10.1002/ccd.30156    DOI
6 van Rosendael PJ, Kamperidis V, van der Kley F, et al. Atherosclerosis burden of the aortic valve and aorta and risk of acute kidney injury after transcatheter aortic valve implantation. J Cardiovasc Comput Tomogr 2015;9:129-38. https://doi.org/10.1016/j.jcct.2015.01.012    DOI
7 Thyregod HG, Steinbruchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol 2015;65:2184-94. https://doi.org/10.1016/j.jacc.2015.03.014    DOI
8 Garcia S, Cubeddu RJ, Hahn RT, et al. 5-Year outcomes comparing surgical versus transcatheter aortic valve replacement in patients with chronic kidney disease. JACC Cardiovasc Interv 2021;14:1995-2005. https://doi.org/10.1016/j.jcin.2021.07.004    DOI
9 Mujtaba SS, Ledingham SM, Shah AR, Pillay T, Schueler S, Clark S. Aortic valve replacement with a conventional stented bioprosthesis versus sutureless bioprosthesis: a study of 763 patients. Braz J Cardiovasc Surg 2018;33:122-8. https://doi.org/10.21470/1678-9741-2017-0088    DOI
10 Horst M, Mehlhorn U, Hoerstrup SP, Suedkamp M, de Vivie ER. Cardiac surgery in patients with end-stage renal disease: 10-year experience. Ann Thorac Surg 2000;69:96-101. https://doi.org/10.1016/s0003-4975(99)01133-9    DOI
11 Biancari F, Pykari J, Savontaus M, et al. Early and late pace-maker implantation after transcatheter and surgical aortic valve replacement. Catheter Cardiovasc Interv 2021;97:E560-8. https://doi.org/10.1002/ccd.29177    DOI
12 Sammour Y, Krishnaswamy A, Kumar A, et al. Incidence, predictors, and implications of permanent pacemaker requirement after transcatheter aortic valve replacement. JACC Cardiovasc Interv 2021;14:115-34. https://doi.org/10.1016/j.jcin.2020.09.063    DOI
13 Vahanian A, Urena M, Walther T, et al. Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial. EuroIntervention 2016;12:e235-43. https://doi.org/10.4244/EIJV12I2A37    DOI
14 Rogers T, Steinvil A, Buchanan K, et al. Contemporary transcatheter aortic valve replacement with third-generation balloon-expandable versus self-expanding devices. J Interv Cardiol 2017;30:356-61. https://doi.org/10.1111/joic.12389    DOI
15 Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98. https://doi.org/10.1056/NEJMoa1103510    DOI
16 Cha MJ, Oh GC, Ki YJ, et al. Time course and risk factors of new-onset complete atrioventricular block after transcatheter aortic valve implantation. Int Heart J 2021;62:988-96. https://doi.org/10.1536/ihj.20-824    DOI
17 Brandenburg VM, Schuh A, Kramann R. Valvular calcification in chronic kidney disease. Adv Chronic Kidney Dis 2019;26:464-71. https://doi.org/10.1053/j.ackd.2019.10.004   DOI
18 Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009;373:956-66. https://doi.org/10.1016/S0140-6736(09)60211-7    DOI
19 Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609-20. https://doi.org/10.1056/NEJMoa1514616    DOI
20 Leon MB, Mack MJ, Hahn RT, et al. Outcomes 2 years after transcatheter aortic valve replacement in patients at low surgical risk. J Am Coll Cardiol 2021;77:1149-61. https://doi.org/10.1016/j.jacc.2020.12.052    DOI
21 Marwick TH, Amann K, Bangalore S, et al. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2019;96:836-49. https://doi.org/10.1016/j.kint.2019.06.025    DOI
22 Rattazzi M, Bertacco E, Del Vecchio A, Puato M, Faggin E, Pauletto P. Aortic valve calcification in chronic kidney disease. Nephrol Dial Transplant 2013;28:2968-76. https://doi.org/10.1093/ndt/gft310    DOI
23 Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007;116:85-97. https://doi.org/10.1161/CIRCULATIONAHA.106.678342    DOI
24 Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2017;14:e275-444. https://doi.org/10.1016/j.hrthm.2017.05.012    DOI
25 Vives M, Hernandez A, Parramon F, et al. Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis 2019;12:153-66. https://doi.org/10.2147/IJNRD.S167477    DOI
26 Chatani K, Abdel-Wahab M, Wubken-Kleinfeld N, et al. Acute kidney injury after transcatheter aortic valve implantation: impact of contrast agents, predictive factors, and prognostic importance in 203 patients with long-term follow-up. J Cardiol 2015;66:514-9. https://doi.org/10.1016/j.jjcc.2015.02.007    DOI
27 Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis 2007;50:169-80. https://doi.org/10.1053/j.ajkd.2007.06.013    DOI
28 Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12. https://doi.org/10.1186/cc2872    DOI